Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

10.8%

84 terminated/withdrawn out of 776 trials

Success Rate

86.8%

+0.3% vs industry average

Late-Stage Pipeline

39%

299 trials in Phase 3/4

Results Transparency

35%

196 of 553 completed trials have results

Key Signals

34 recruiting196 with results67 terminated17 withdrawn

Enrollment Performance

Analytics

Phase 3
165(26.9%)
Phase 4
134(21.8%)
N/A
130(21.2%)
Phase 2
111(18.1%)
Phase 1
73(11.9%)
Early Phase 1
1(0.2%)
614Total
Phase 3(165)
Phase 4(134)
N/A(130)
Phase 2(111)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (776)

Showing 20 of 776 trials
NCT01366144Phase 1Active Not Recruiting

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Role: collaborator

NCT00931463Phase 4Completed

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Role: collaborator

NCT05324683Active Not Recruiting

ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)

Role: collaborator

NCT05387954Phase 3Recruiting

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Role: collaborator

NCT04818645Not ApplicableActive Not Recruiting

Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients

Role: collaborator

NCT05198791Phase 2Recruiting

Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.

Role: collaborator

NCT04419480Not ApplicableRecruiting

Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

Role: collaborator

NCT06883864Not ApplicableRecruiting

Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial

Role: collaborator

NCT06262295Recruiting

A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP (France LEADLESS)

Role: collaborator

NCT06815536Recruiting

Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae

Role: collaborator

NCT07135531Not ApplicableNot Yet Recruiting

Continuous Glucose Monitoring (CGM) in an Underserved Population

Role: collaborator

NCT05687591Completed

Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast Asia Observational Study

Role: collaborator

NCT07422688Not ApplicableEnrolling By Invitation

Optical Coherence Tomography in Acute Vessel Evaluation

Role: collaborator

NCT05705427Phase 4Completed

The COMBAT HBV Feasibility Trial

Role: collaborator

NCT03682991Not ApplicableActive Not Recruiting

Reversal of Atrial Substrate to Prevent Atrial

Role: collaborator

NCT07271043Not ApplicableRecruiting

Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics

Role: collaborator

NCT05599061Not ApplicableRecruiting

Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial

Role: collaborator

NCT07359898Recruiting

International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aortic Valve Platform

Role: collaborator

NCT07240012Not ApplicableRecruiting

Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes

Role: collaborator

NCT04354077Not ApplicableRecruiting

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

Role: collaborator